Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About NUS Interactive Breakdown Better Bets vs. NUS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Nu Skin Enterprises (NUS)

Market Price (10/25/2025): $11.02 | Market Cap: $544.8 Mil
Sector: Consumer Staples | Industry: Household Products

Nu Skin Enterprises (NUS)

Market Price (10/25/2025): $11.02
Market Cap: $544.8 Mil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 21%, Dividend Yield is 2.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 16%, FCF Yield is 11%		 Weak multi-year price returns
2Y Excs Rtn is -100%, 3Y Excs Rtn is -150%		 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -12%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13%, Rev Chg QQuarterly Revenue Change % is -12%
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 21%, Dividend Yield is 2.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 16%, FCF Yield is 11%
1 Weak multi-year price returns
2Y Excs Rtn is -100%, 3Y Excs Rtn is -150%
2 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -12%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13%, Rev Chg QQuarterly Revenue Change % is -12%

Market Valuation & Key Metrics

NUSS&P 500
REVENUE GROWTHVERY POOR
Rev LTM ($ Bil)1.6
Rev Chg Q-12.1%6.3%
Rev Chg LTM-11.8%5.2%
Rev Chg 3Y Avg-13.1%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)0.1
CFO LTM ($ Bil)0.1
Net Inc LTM ($ Bil)0.1
Op Mgn LTM3.5%18.7%
CFO/Rev LTM5.7%20.4%
Net Inc Mgn6.2%12.7%
VALUATIONVERY LOW
P/S0.33.3
P/CFO5.816.0
P/FCF9.321.0
P/E5.424.1
STABILITYGOOD
Debt/Equity0.570.21
Cash/Assets0.180.07

NUS Stock

   
   
   
   
   
   
   

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
NUS Return39%-4%-14%-51%-64%62%-68%
Peers Return120%-3%-17%6%-8%-35%13%
S&P 500 Return16%27%-19%24%23%15%106%

Monthly Win Rates [3]
NUS Win Rate67%42%50%25%33%56% 
Peers Win Rate53%35%32%38%47%42% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
NUS Max Drawdown-69%-26%-36%-60%-68%-20% 
Peers Max Drawdown-27%-24%-27%-14%-20%-51% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADUS, USPH, OMI, SLP, DSY. See NUS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/24/2025 (YTD)

How Low Can It Go

Unique KeyEventNUSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-73.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven282.4%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-70.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven239.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven106 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-55.9%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven126.6%24.7%
2018 CorrectionTime to BreakevenTime to BreakevenNot Fully Recovered days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-59.1%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven144.7%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven210 days1480 days

Compare to ADUS, USPH, OMI, SLP, DSY


In The Past

Nu Skin Enterprises's stock fell -73.8% during the 2022 Inflation Shock from a high on 6/9/2021. A -73.8% loss requires a 282.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Nu Skin Enterprises (NUS)

Better Bets than Nu Skin Enterprises (NUS)

 NUSBetter Performance than NUS
MetricValueIndustry (Household Products)
Rev Chg LTM-11.8%UL (11.1%), CL (0.1%), KMB (-3.1%), CHD (1.1%), CLX (0.2%)
Rev Chg 3Y Avg-13.1%UL (3.4%), CL (4.2%), KMB (-2.1%), CHD (4.6%), CLX (0.0%)
Op Mgn LTM3.5%UL (14.4%), CL (21.7%), KMB (16.7%), CHD (17.8%), CLX (16.7%)
CFO/Rev LTM5.7%UL (12.4%), CL (19.6%), KMB (15.2%), CHD (17.7%), CLX (13.8%)
FCF/Rev LTM3.6%UL (12.4%), CL (16.9%), KMB (11.1%), CHD (15.3%), CLX (10.7%)
Total Yield20.7%
 NUSBetter Performance than NUS
MetricValueAll Other Sectors
Rev Chg LTM-11.8%NVDA (71.6%), AAPL (6.0%), MSFT (14.9%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg-13.1%NVDA (92.0%), AAPL (1.8%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%)
Op Mgn LTM3.5%NVDA (58.1%), AAPL (31.9%), MSFT (45.6%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM5.7%NVDA (46.6%), AAPL (26.6%), MSFT (48.3%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM3.6%NVDA (43.6%), AAPL (23.5%), MSFT (25.4%), GOOGL (18.0%), META (30.7%)
Total Yield20.7%BABA (36.1%), TM (2036.8%), HMC (2140.7%), BIDU (66.8%), ERIC (78.2%)
null

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Nu Skin Enterprises Stock Fell 8.2% in a Month, What Now?Return 
2Nu Skin Enterprises vs. S&P500 CorrelationCorrelation 
3Nu Skin Enterprises Price VolatilityVolatility 
4Day 5 of Loss Streak for Nu Skin Enterprises Stock with -30% Return (vs. -37% YTD) [2/23/2024]Notification 
5Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month  
6Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month  
7[11/3/2022] Nu Skin Enterprises (NUS) Shares Moved -13% Today  (Extremely rare event)  
8Dates Cached For NUS  
9Nu Skin Enterprises vs. Mid Cap Stocks: Which Is A Better Investment?Investment Theme Comparisons 
10Nu Skin Enterprises vs. Beauty Stocks: Which Is A Better Investment?Investment Theme Comparisons 
11ARTICLES  
12Up 8% In One Week, Can Nu Skin Enterprises Stock Continue Its Post-Earnings Rally? February 23rd, 2022
13What’s Next For Nu Skin Stock After The Recent 12% Rise Last Week? May 11th, 2021
Title
0DASHBOARDS
1Up 8% In One Week, Can Nu Skin Enterprises Stock Continue Its Post-Earnings Rally?
2What’s Next For Nu Skin Stock After The Recent 12% Rise Last Week?
3ARTICLES
4Nu Skin Enterprises Stock Fell 8.2% in a Month, What Now?
5Nu Skin Enterprises vs. S&P500 Correlation
6Nu Skin Enterprises Price Volatility
7Day 5 of Loss Streak for Nu Skin Enterprises Stock with -30% Return (vs. -37% YTD) [2/23/2024]
8Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month
9Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month
10[11/3/2022] Nu Skin Enterprises (NUS) Shares Moved -13% Today  (Extremely rare event)
11Dates Cached For NUS
12Nu Skin Enterprises vs. Mid Cap Stocks: Which Is A Better Investment?
13Nu Skin Enterprises vs. Beauty Stocks: Which Is A Better Investment?

Trade Ideas

Select past ideas related to NUS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-0.4%-0.4%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.8%0.8%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-16.4%-16.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.5%5.5%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-14.3%-14.3%-22.4%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-0.4%-0.4%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.8%0.8%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-16.4%-16.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.5%5.5%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-14.3%-14.3%-22.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1498.4%344.0%
2PRAXPraxis Precision Medicines253.2%126.1%
3NVTSNavitas Semiconductor116.1%294.1%
4SNDKSanDisk97.4% 
5UAMYUnited States Antimony90.3%578.5%
6GRALGRAIL85.2%400.8%
7BALYBallys82.9%6.8%
8ORKAOruka Therapeutics81.1%40.5%
9INBXInhibrx Biosciences79.9%272.0%
10CIFRCipher Mining77.2%345.3%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1VGVenture Global-35.7% 
2PMIPicard Medical-35.3%8328.6%
3SOCSable Offshore-33.7%-41.7%
4FWRDForward Air-28.9%-39.0%
5FLYFirefly Aerospace-28.5% 
6ITGRInteger-28.4%-45.0%
7USNAUsana Health Sciences-26.5%-42.0%
8HTZHertz Global-26.3%41.5%
9RCReady Capital-25.1%-50.3%
10ULHUniversal Logistics-24.8%-61.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Nu Skin Enterprises

Financials

NUSADUSUSPHOMISLPDSYMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Simulati.Big Tree. 
Mkt Price11.02121.6393.165.5117.830.7114.42
Mkt Cap0.52.21.40.40.4-0.5
Rev LTM1,6261,2747308,73180-1,274
Op Inc LTM57116712875-71
FCF LTM599461-16611-59
FCF 3Y Avg56966313014-63
CFO LTM931007210114-93
CFO 3Y Avg1071047335319-104

Growth & Margins

NUSADUSUSPHOMISLPDSYMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Simulati.Big Tree. 
Rev Chg LTM-11.8%14.3%16.2%2.5%20.0%-14.3%
Rev Chg 3Y Avg-13.1%12.1%11.4%-3.6%15.8%-11.4%
Rev Chg Q-12.1%21.8%18.0%3.3%9.8%-9.8%
QoQ Delta Rev Chg LTM-3.2%5.2%4.3%0.2%2.3%-2.3%
Op Mgn LTM3.5%9.1%9.7%3.3%5.8%-5.8%
Op Mgn 3Y Avg3.9%8.7%10.7%2.8%11.2%-8.7%
QoQ Delta Op Mgn LTM0.5%0.1%0.2%0.1%1.3%-0.2%
CFO/Rev LTM5.7%7.9%9.8%1.2%17.7%-7.9%
CFO/Rev 3Y Avg5.9%9.3%11.4%3.7%29.2%-9.3%
FCF/Rev LTM3.6%7.4%8.3%-1.9%13.1%-7.4%
FCF/Rev 3Y Avg3.2%8.6%9.9%1.3%22.9%-8.6%

Valuation

NUSADUSUSPHOMISLPDSYMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Simulati.Big Tree. 
Mkt Cap0.52.21.40.40.4-0.5
P/S0.31.71.90.04.5-1.7
P/EBIT4.018.217.8-1.476.6-17.8
P/E5.426.542.4-0.4-5.7-5.4
P/CFO5.821.919.74.225.2-19.7
Total Yield20.7%3.8%3.3%-283.8%-17.3%-3.3%
Dividend Yield2.2%0.0%0.9%0.0%0.3%-0.3%
FCF Yield 3Y Avg11.8%5.4%4.6%6.1%2.2%-5.4%
D/E0.60.10.24.90.0-0.2
Net D/E0.10.10.24.8-0.1-0.1

Returns

NUSADUSUSPHOMISLPDSYMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Simulati.Big Tree. 
1M Rtn-7.2%4.1%13.8%4.4%20.1%-41.9%4.2%
3M Rtn26.6%11.1%26.1%-30.1%34.8%-45.9%18.6%
6M Rtn93.3%20.9%33.6%-20.7%-49.8%-47.8%0.1%
12M Rtn80.5%-5.8%16.3%-59.7%-42.4%-81.1%-24.1%
3Y Rtn-67.6%12.3%16.5%-67.1%-61.1%--61.1%
1M Excs Rtn-11.0%2.4%10.1%11.0%18.6%-43.8%6.2%
3M Excs Rtn18.3%5.2%18.0%-36.3%24.4%-51.1%11.6%
6M Excs Rtn70.4%-2.0%10.7%-43.6%-72.7%-70.7%-22.8%
12M Excs Rtn70.0%-22.6%-1.2%-75.2%-64.0%-100.9%-43.3%
3Y Excs Rtn-149.7%-67.0%-60.9%-149.8%-144.8%--144.8%

Comparison Analyses

Title
0Nu Skin Enterprises vs. Marvell Technology Group: Similar Revenue, But Marvell Technology Group Is A Better Bet
1Nu Skin Enterprises vs. Fortinet: Similar Revenue, Similar Bets
2Nu Skin Enterprises vs. Cadence Design Systems: Similar Revenue, But Nu Skin Enterprises Is A Better Bet
3Nu Skin Enterprises vs. Blackbaud: Similar Market Cap, But Blackbaud Is A Better Bet
4Nu Skin Enterprises vs. Allegiant Travel Company: Similar Market Cap, But Allegiant Travel Company Is A Better Bet
5Nu Skin Enterprises vs. Installed Building Products: Similar Market Cap, But Installed Building Products Is A Better Bet
6Nu Skin Enterprises vs Addus HomeCare: Industry Peers; Which Stock Is A Better Bet?
7Nu Skin Enterprises vs Plexus: Similar Market Cap; Which Stock Is A Better Bet?
8Nu Skin Enterprises vs Box: Similar Market Cap; Which Stock Is A Better Bet?
9Nu Skin Enterprises vs Corcept Therapeutics: Similar Market Cap; Which Stock Is A Better Bet?

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/8/20255/9/20252/14/202511/8/20248/9/20245/9/20242/15/202411/2/20238/2/20235/4/20232/16/202311/3/2022
Key Financials Quarterly            
Total Revenue386364446430439417489499500481522538
Ebitda43152-3537-1072735-96036828
Operating Income3115-718241626-2643264610
Net Income21108-368-118-17-37271157-25
EPS0.432.16-0.730.17-2.38-0.010.15-0.740.540.231.16-0.51
Key Financials TTM            
Total Revenue TTM1,6261,6791,7321,7751,8441,9051,9692,0032,0422,1022,2262,377
Ebitda TTM19746-79-8-5411312395132142175258
Operating Income TTM5750518439586888124133159186
Net Income TTM101-39-147-103-148-3959707710538
Growth Rates Quarterly            
Total Revenue Growth-12.1%-12.7%-8.8%-13.8%-12.2%-13.3%-6.5%-7.3%-10.8%-20.4%-22.4%-16.1%
EBITDA Growth140.1%466.2%-200.6%525.5%-278.7%-26.3%369.0%-131.1%-14.4%-47.4%-91.7%-67.2%
Operating Income Growth29.4%-4.7%-127.6%169.1%-44.0%-38.3%-43.1%-367.9%-17.5%-50.4%-36.5%-85.0%
Net Income Growth117.9%20271.7%-595.8%122.5%-539.8%-104.7%-87.3%-45.5%-21.5%-70.6%719.8%-151.1%
Margins Quarterly            
EBITDA Margin11.1%41.7%-8.0%8.6%-24.4%6.4%7.2%-1.7%12.0%7.6%1.4%5.2%
Operating Income Margin8.0%4.2%-1.6%4.2%5.4%3.8%5.3%-5.3%8.5%5.4%8.8%1.8%
Net Income Margin5.5%29.5%-8.1%1.9%-26.9%-0.1%1.5%-7.4%5.4%2.4%11.0%-4.7%
Cash & Debt            
Total Cash265214198238233221268250252247279308
Total Debt311301478502529557607571582499521503
Net Debt / (Cash)4587280264296336340321330252242195
Cash Flows Quarterly            
FCF from Operations3602631513545136-222628
Cash Flows TTM            
FCF from Operations TTM93109112140160144119906778108192
Returns to Shareholders Quarterly            
Dividends333333191919191919
Share Repurchases-05-0-0-0-0-013-0-01040
Return on Invested Capital (ROIC) Quarterly            
ROIC209.1%55.8%-6.4%17.2%28.9%19.0%24.0%-32.8%37.3%32.0%75.7%17.7%
Return on Invested Capital (ROIC) TTM            
ROIC TTM107.8%53.3%15.2%30.4%12.7%17.3%6.5%27.3%37.6%52.8%65.8%44.0%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Nu Skin1,7532,0682,523  
Manufacturing181149172  
Rhyz other3540  
Core Nu Skin Adjustments-14   
Beauty   1,4921,423
Other   168134
Wellness   923863
Total1,9692,2262,6962,5822,420


Operating Income by Segment
$ Mil20242023202220212020
Nu Skin376425572  
Manufacturing12418  
Rhyz other-21-6-2  
Corporate and other-320-311-354  
Total48111234  


Price Behavior

NUS Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta3.032.272.261.010.880.91
Up Beta4.044.115.110.770.770.87
Down Beta3.652.313.521.271.211.15
Up Capture193%332%218%175%100%23%
Bmk +ve Days13233574144420
Stock +ve Days11243360119353
Down Capture393%-7%-83%86%66%102%
Bmk -ve Days8192952107330
Stock -ve Days10183065127388

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity2,173,387
Short Interest: % Change Since 9302025-6.6%
Average Daily Volume482,360
Days-to-Cover Short Interest4.51
Basic Shares Quantity49,441,000
Short % of Basic Shares4.4%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/7/20258.9%39.5%41.1%
5/8/202511.0%21.3%31.5%
2/13/202517.8%18.4%29.5%
11/7/20241.6%11.5%21.7%
8/8/2024-3.2%-5.1%-29.4%
5/8/20242.9%9.4%7.1%
2/14/2024-20.7%-29.5%-23.6%
11/1/2023-9.5%-12.0%-3.5%
...
SUMMARY STATS   
# Positive111112
# Negative131312
Median Positive8.9%9.8%15.5%
Median Negative-7.6%-8.9%-15.5%
Max Positive27.9%39.5%45.5%
Max Negative-20.7%-29.5%-44.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025808202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024214202510-K 12/31/2024
93020241108202410-Q 9/30/2024
6302024809202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023215202410-K 12/31/2023
93020231102202310-Q 9/30/2023
6302023802202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022216202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021216202210-K 12/31/2021
93020211104202110-Q 9/30/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.